Medtronic (NYSE:MDT) is asking a federal judge in Mississippi to dismiss a whistleblower lawsuit accusing it of installing a stooge, spinal surgeon Dr. Thomas Zdeblick, as editor of an influential spine journal to push positive – and possibly premature – data on its Infuse bone growth stimulant.
Legal News
Supreme Court reopens Obamacare challenge | MassDevice.com On Call
MASSDEVICE ON CALL — The Supreme Court this week revisited the landmark healthcare reform decision that originally upheld the Affordable Care Act’s individual insurance mandate.
The Supreme Court decided to allow a lower court to proceed with a case against the law, getting the Obama administration’s nod to do so.
Becton Dickinson to close the books on a $45 million antitrust lawsuit
Healthcare giant Becton Dickinson & Co. (NYSE:BDX) may finally close the books on a years-long lawsuit after a New Jersey judge authorized a $45 million settlement to the company’s hypodermic product purchasers.
Endotach sues Medtronic over stent graft patents
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor’s widow, according to court documents.
Cardium Therapeutics claims patent win over Boston Scientific
Medtronic brass: Edwards lawsuit hits profits, but has no impact on CoreValve timeline
Stryker exec charged in $1.7M insider trading scheme | MassDevice.com On Call
Shareholders sue Abiomed over Impella claims
Texas DePuy hip implant lawsuit docket tops 750 complaints
A Lone Star State multi-district lawsuit against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics has grown to include 757 complaints as federal courts around the country transfer cases to the Northern District of Texas.